In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

about

Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.Lack of effect of DX-619, a novel des-fluoro(6)-quinolone, on glomerular filtration rate measured by serum clearance of cold iohexol.

P2860

Q34298846-34131B59-5120-4032-B35F-64A0F990C821 Q35840780-1E49AFC1-DCA3-4854-8DF9-CE86C3A4FDEF

P2860

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

Item

http://www.wikidata.org/entity/Q41976061

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

@en

type

Item

label

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

@en

prefLabel

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

@en

P1476

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

@en

P2093

Ellen Smith Moland

http://www.w3.org/2001/XMLSchema#string

Jennifer A Black

http://www.w3.org/2001/XMLSchema#string

Kenneth S Thomson

http://www.w3.org/2001/XMLSchema#string

Paul A Wickman

http://www.w3.org/2001/XMLSchema#string

P2860

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.

In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone.

Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model.

Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones.

The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001

P304

2255-2257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00011-06

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16723599

http://www.w3.org/2001/XMLSchema#string

P921

quinolone

Gram-positive bacteria

P932

1479102

http://www.w3.org/2001/XMLSchema#string

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

about

P2860

P2860

In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932